SK Biopharmaceuticals and AriBio Enter into a Strategic Alliance SEOUL, Korea--(BUSINESS WIRE)--SK Biopharmaceuticals and AriBio have agreed to collaborate on the development for glaucoma of SKL-G, noted for its preclinical lowering of intraocular pressure and prevention of optic nerve death.
July 3, 2013 - Business Wire